The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Background: In patients (pts) with acute coronary syndromes microembolization from ruptured atherosclerotic plaques may cause minor myocardial injury detectable by circulating troponins. This was shown to be associated with an adverse short and long term outcome. The CAPTURE trial demonstrated that platelet inhibition with abciximab reduces risk for myocardial infarction (AMI) and death in pts with...
Background: Circulating cardiac troponin I (cTnI) is a sensitive biochemical marker for detection of myocardial cell damage and has been shown to be related to adverse short term prognosis in patients (pts) with acute coronary syndrome (ACS). We investigated prospectively the value of rapid bedside cTnI testing in n = 773 pts with acute chest pain but without ST-elevation in the electrocardiogram...